To date, circulating CXCL1 has never been evaluated as a marker of disease activity in patients with SLE despite a broad theoretical basis in the literature suggesting that chemokines contribute to the pathogenesis of SLE and LN. The gene discussed is CXCL1; the disease is systemic lupus erythematosus.